1. Protocatechualdehyde Protects Against Cerebral Ischemia-Reperfusion-Induced Oxidative Injury Via Protein Kinase Cε/Nrf2/HO-1 Pathway.
- Author
-
Guo C, Wang S, Duan J, Jia N, Zhu Y, Ding Y, Guan Y, Wei G, Yin Y, Xi M, and Wen A
- Subjects
- Animals, Anticoagulants pharmacology, Anticoagulants therapeutic use, Benzaldehydes pharmacology, Brain Ischemia drug therapy, Catechols pharmacology, Cell Line, Tumor, Dose-Response Relationship, Drug, Humans, Male, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Oxidative Stress drug effects, Random Allocation, Rats, Rats, Sprague-Dawley, Reperfusion Injury prevention & control, Signal Transduction drug effects, Signal Transduction physiology, Benzaldehydes therapeutic use, Brain Ischemia metabolism, Catechols therapeutic use, Heme Oxygenase-1 biosynthesis, Membrane Proteins biosynthesis, NF-E2-Related Factor 2 metabolism, Oxidative Stress physiology, Protein Kinase C-epsilon metabolism, Reperfusion Injury metabolism
- Abstract
Oxidative stress is closely related to the pathogenesis of ischemic stroke. Protocatechualdehyde (PCA) is a phenolic acid compound that has the putative antioxidant activities. The present study was aimed to investigate the molecular mechanisms involved in the antioxidative effect of PCA against cerebral ischemia/reperfusion (I/R) injury. The experiment stroke model was produced in Sprague-Dawley rats via middle cerebral artery occlusion (MCAO). To model ischemia-like conditions in vitro, differentiated SH-SY5Y cells were exposed to transient oxygen and glucose deprivation (OGD). Treatment with PCA significantly improved neurologic score, reduced infarct volume and necrotic neurons, and also decreased reactive oxygen species (ROS) production, 4-hydroxynonenal (4-HNE), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) contents at 24 h after reperfusion. Meanwhile, PCA significantly increased the transcription nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) expressions in the ischemic cerebral cortex as shown by immunofluorescence staining and Western blot analysis. In vitro experiment showed that PCA protected differentiated SH-SY5Y cells against OGD-induced injury. Likewise, PCA also increased markedly the Nrf2 and HO-1 expressions in a dose-dependent manner. The neuroprotection effect of PCA was abolished by knockdown of Nrf2 and HO-1. Moreover, knockdown of protein kinase Cε (PKCε) also blocked PCA-induced Nfr2 nuclear translocation, HO-1 expression, and neuroprotection. Taken together, these results provide evidences that PCA can protect against cerebral ischemia-reperfusion-induced oxidative injury, and the neuroprotective effect involves the PKCε/Nrf2/HO-1 pathway.
- Published
- 2017
- Full Text
- View/download PDF